EEG Classification System for Dementia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02273921|
Recruitment Status : Unknown
Verified October 2014 by Mentis Cura.
Recruitment status was: Enrolling by invitation
First Posted : October 24, 2014
Last Update Posted : October 24, 2014
The goal of this study is to construct a large database of EEG recordings from elderly individuals in predefined groups. The purpose of this database is to select groups of EEG recordings from the database in order to compare the electrophysiology, as measured by EEG, of the groups.
In the clinical trial part all individuals are treated exactly the same and are therefore considered a single group. The categorization is performed during the data analysis.
The groups in the data analysis will initially be based on the following:
- Healthy controls
- Mild Cognitive Impairment
- Alzheimers Disease (AD)
- Lewy-body Dementia
- Parkinsons Disease Dementia
- Vascular Dementia (VaD)
- Frontotemporal Dementia (FTD)
Other groups will be added if needed.
|Condition or disease||Intervention/treatment||Phase|
|Dementia||Other: EEG recording||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2000 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||EEG Classification System for Dementia|
|Study Start Date :||March 2005|
|Estimated Primary Completion Date :||June 2020|
|Estimated Study Completion Date :||June 2020|
No Intervention: EEG
A non-invasive EEG recording
Other: EEG recording
EEG is recorded once for each participant
- Classification system for dementia based on EEG [ Time Frame: The quality of the classification system will be evaluated regularly, at least every 6 months, up to 6 years. ]The EEGs recorded in the trial will be categorized into controls or predefined clinical groups based on the participants' clinical diagnosis. The classification system will be constructed using this categorization.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02273921
|Principal Investigator:||Jón Snædal, MD||Landspitali University Hospital|